【肝癌】透過血清融合基因機器學習，可將「肝細胞癌」患者存活率從20%提高至90%

 【肝癌】透過血清融合基因機器學習，可將「肝細胞癌」患者存活率從20%提高至90%

 文章出處  

Pathology 

 

 原文標題  

Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine Learning 

 

 文章序號  

5782 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.